Up a level |
Kudo, Masatoshi, Galle, Peter R, Brandi, Giovanni, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S, Llovet, Josep M, Assenat, Eric, Merle, Philippe, Chan, Stephen L et al (show 11 more authors)
(2021)
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2.
JHEP REPORTS, 3 (2).
100215-.
Meyer, Tim, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Cheng, Ann-Lii, Hocke, Julia, Loembe, Arsene-Bienvenu and Yen, Chia-Jui
(2017)
mRECIST to predict survival in advanced hepatocellular carcinoma: Analysis of two randomised phase II trials comparing nintedanib vs sorafenib.
LIVER INTERNATIONAL, 37 (07).
pp. 1047-1055.